Universal CAR-T Cell Therapy for Refractory Lupus Nephritis
NCT06681337
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Lupus Nephritis
Interventions
BIOLOGICAL:
BCMA CART + CD19 CART
Sponsor
Bioray Laboratories
Collaborators
[object Object]